Literature DB >> 8052307

Phosphatidylinositol-3-OH kinase as a direct target of Ras.

P Rodriguez-Viciana1, P H Warne, R Dhand, B Vanhaesebroeck, I Gout, M J Fry, M D Waterfield, J Downward.   

Abstract

Ras (p21ras) interacts directly with the catalytic subunit of phosphatidylinositol-3-OH kinase in a GTP-dependent manner through the Ras effector site. In vivo, dominant negative Ras mutant N17 inhibits growth factor induced production of 3' phosphorylated phosphoinositides in PC12 cells, and transfection of Ras, but not Raf, into COS cells results in a large elevation in the level of these lipids. Therefore Ras can probably regulate phosphatidylinositol-3-OH kinase, providing a point of divergence in signalling pathways downstream of Ras.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052307     DOI: 10.1038/370527a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  545 in total

1.  S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3.

Authors:  A Chiloeches; C S Mason; R Marais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.

Authors:  L Wang; H Hayashi; K Kishi; L Huang; A Hagi; K Tamaoka; P T Hawkins; Y Ebina
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.

Authors:  D Tulasne; R Paumelle; K M Weidner; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

4.  Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway.

Authors:  S Gupta; R Plattner; C J Der; E J Stanbridge
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  ShcA tyrosine phosphorylation sites can replace ShcA binding in signalling by middle T-antigen.

Authors:  P R Nicholson; S Empereur; H R Glover; S M Dilworth
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

6.  Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts.

Authors:  Geraldine Pawlak; David M Helfman
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

7.  Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Authors:  Janiel M Shields; Heena Mehta; Kevin Pruitt; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 8.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 9.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

10.  Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2.

Authors:  Si Qing Zhang; William G Tsiaras; Toshiyuki Araki; Gengyun Wen; Liliana Minichiello; Ruediger Klein; Benjamin G Neel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.